Clinical outcomes according to the modified endoscopic criteria for neoadjuvant chemotherapy in resectable esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical outcomes according to the modified endoscopic criteria for neoadjuvant chemotherapy in resectable esophageal squamous cell carcinoma

Published:2020-03 Issue:3 Volume:32 Page:337-345
ISSN:0915-5635
Container-title:Digestive Endoscopy
language:en
Short-container-title:Digestive Endoscopy

Author:

Kadota Tomohiro¹^ORCID,Abe Seiichiro²,Yoda Yusuke¹,Yoshinaga Shigetaka²,Oda Ichiro²,Kojima Takashi³,Kato Ken⁴,Daiko Hiroyuki⁵⁶,Yano Tomonori¹

Affiliation:

1. Department of Gastroenterology and EndoscopyNational Cancer Center Hospital EastChiba Japan

2. Endoscopy DivisionNational Cancer Center HospitalTokyo Japan

3. Department of Gastroenterology Gastrointestinal Oncology DivisionNational Cancer Center Hospital EastChiba Japan

4. Gastrointestinal Medical Oncology DivisionsNational Cancer Center HospitalTokyo Japan

5. Department of Esophageal Surgery National Cancer Center Hospital East ChibaJapan

6. Esophageal Surgery Division National Cancer Center Hospital Tokyo Japan

Publisher

Wiley

Subject

Gastroenterology,Radiology Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/den.13483

Reference21 articles.

1. Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus

2. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

3. A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

4. Early response to neoadjuvant chemotherapy in advanced esophageal cancer evaluated by computed tomography predicts the utility of a second cycle of chemotherapy

5. Outcomes of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil Followed by Esophagectomy in Patients with Resectable Node-Positive Esophageal Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remarkable response as a new indicator for endoscopic evaluation of local efficacy of non-surgical treatments for esophageal cancer;Esophagus;2024-02-14

2. Review of the Japanese Classification of Esophageal Cancer 12th Edition, and Proposals for the 13th Edition;Annals of Thoracic and Cardiovascular Surgery;2024

3. Collaborative multidisciplinary management and expertise of cT2–3 locally advanced operable esophageal squamous cell carcinoma: a report of two cases;Journal of Thoracic Disease;2023-11

4. Prognostic impact of endoscopic response evaluation after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a nationwide validation study;Esophagus;2023-03-24

5. Randomized study of prevention of gastrointestinal toxicities by nutritional support using an amino acid-rich elemental diet during chemotherapy in patients with esophageal cancer (KDOG 1101);Esophagus;2020-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3